Abstract. The present study was designed to extensively characterize cell lines derived from porcine blastocysts by several methodical approaches, including morphological observation, cytogenetic analysis, estimation of alkaline phosphatase activity and detection of specific marker expression at the mRNA/protein level. A comparison was made between the properties of cell lines isolated from in vivo-and in vitro-obtained blastocysts. Our results showed that 57.1% of the in vivo-obtained blastocysts attached to the feeder layer and that 33.3% of them started to grow in a monolayer. The percentage of attached in vitro-produced blastocysts was lower (24.6%), and only 6.9% of them started to grow. Outgrowths from the in vitro-produced blastocysts formed mainly trophectoderm or epithelial-like monolayer, whereas the in vivo-obtained blastocysts formed heterogeneous outgrowths that also contained cells with embryonic stem (ES)-like morphology. Detailed analyses showed that the primary outgrowths with ES-like morphology expressed the pluripotency markers OCT-4 and NANOG and revealed intensive alkaline phosphatase staining, while they did not express markers of differentiation. The majority of passaged cells, including those with ESlike morphology, lacked OCT-4 protein and revealed expression of specific differentiation markers (CYTOKERATIN 18, LAMINS A/C, TRANSFERRIN, α-FETOPROTEIN and GATA-4), although they still expressed NANOG and exhibited weak alkaline phosphatase activity. Moreover, these cells spontaneously differentiated into neural, fibroblast or epithelial-like cells, even in the presence of leukaemia inhibitory factor. Our results show that complex analysis of markers of pluripotency as well as differentiation markers is necessary for proper interpretation of data in porcine embryonic stem cell studies. Key words: Blastocyst, In vitro, In vivo, Pig, Stem cells (J. Reprod. Dev. 57: [594][595][596][597][598][599][600][601][602][603] 2011) he successful isolation and characterization of mouse ES (embryonic stem) cell lines [1,2] has resulted in considerable efforts aimed to establish ES cell lines in other species, including humans. ES cells are unique cells with the capacity for unlimited proliferation without differentiation under optimal in vitro conditions and with broad differentiation plasticity in vivo and in vitro. When introduced into blastocysts, they can contribute to all cell lineages, including the germline [3]. Validated ES cells with all of these properties have been isolated only in the mouse and rat [4], as no germline chimeras have been reported in other mammals. The absence of cell lines capable of generating germline chimeras limits the possibility of using farm animal ES cells as tools for genetic manipulation [5]. Since 1998, when pluripotent human ES cell lines were established [6], ES cell research has been mainly focused on therapeutic use in human medicine. Before stem cell therapies are introduced into human medicine, it will be necessary to develop and verify the safety and effecti...